| | | | Index Performance | | Index | Sensex | Nifty | | Open | 16,226.66 | 4,942.15 | | High | 16,226.66 | 4,947.00 | | Low | 15,563.15 | 4,703.85 | | Today's Cls | 15,644.44 | 4,734.50 | | Prev Cls | 16,371.29 | 4,942.00 | | Change | -726.85 | -207.50 | | % Change | -4.44 | -4.20 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Alstom Projects | 581.85 | 6.40 | | Spice Tele | 27.75 | 5.92 | | Cummins India | 317.80 | 4.99 | | Shree Precoated Steel | 180.00 | 4.99 | | ABG Shipyard | 720.00 | 4.93 | | Losers | | Indiabulls Financial | 414.20 | -12.23 | | Reliance Capital | 1,229.50 | -12.08 | | Adlabs Films | 613.15 | -10.34 | | India Infoline | 770.15 | -10.10 | | Godrej Industries | 259.35 | -9.68 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,365 | 437 | | Declines | 1,291 | 742 | | Unchanged | 43 | 18 | | Volume(Nos) | 33.02cr | 57.73cr | | | | | | Market Commentary | | | Market sinks on bear hammering | | The Sensex plummeted 805 points on across-the-board selling pressure. | | The market went into a complete tailspin as the much-awaited correction shaved nearly 800 points off the Sensex during intra-day trades. | | | | Global positive cues like further cooling off of the oil prices failed to lift the sentiment, as investors tracked the falling Asian indices since early trades instead. The Sensex resumed 144 points lower at 16,227 and lost more ground as the trading progressed. The market witnessed a steep fall in early noon trades as selling in heavyweights, Bankex, realty and information technology (IT) dragged the index below the 16,000 mark to the day's low of 15,563. After lingering in negative territory thereafter, the Sensex wrapped up the session at 15,644, down 727 points, while the Nifty shed 208 points to close at 4,735. | | | Movers & Shakers | - Sun Pharmaceuticals declined inspite of the report that the company has launched generic Amifostine injection.
- Larsen & Toubro, which bagged a Rs576-crore order from HPCL, ended at lower levels.
- Suven Life Sciences ended lower despite announcing two product patents in Korea and Mexico.
- Mahindra & Mahindra rose on reports that the company has signed a MoU with government of Maharashtra to invest an additional Rs1,500 crore at Chakan Greenfield.
- BL Kashyap & Sons gained marginally on report that the Company has bagged new projects worth over Rs344 crore for the construction of ~3.60 million sq ft of space.
| | | |
However, the market breadth was marginally positive with the gainers outpacing the losers by 1:0.4. Of the 2,699 stocks traded on the BSE, 1,365 stocks advanced, 1,291 stocks declined and 43 stocks ended unchanged. All the sectoral indices took sharp beating. The BSE Bankex index bore the major brunt and crashed 5.89% at 7,718, while the BSE IT index, the BSE Realty index, the BSE Metal index, the BSE Oil& Gas index and the BSE Teck index dropped over 3-5% each.
Of the 30 stocks in the Sensex pack, 26 ended in red. Among the major losers, HDFC tumbled 8.79% at Rs2,383.75, ICICI Bank slumped 7.79% at Rs770.10, DLF crumbled 7.07% at Rs646.50 and TCS plunged 6.80% at Rs810.90. Infosys dropped 6.30% at Rs1,430, Wipro declined 6.32% at Rs425.30, Reliance Energy fell 6.19% at Rs1,251 and Hindalco moved down 6.10% at Rs164.75. Other frontline stocks also dropped over 1-5% each.
In the Bankex pack, Yes Bank tanked 7.61% at Rs168.75, Bank of India plummeted 7.11% at Rs252.90, Kotak Bank slumped 6.35% at Rs628.55 and HDFC Bank lost 5.79% at Rs1,319. Bank of Baroda, Centurion Bank of Punjab, Oriental Bank of India, SBI, Allahabad Bank, Punjab National Bank, UBI and Andhra Bank crashed over 3.5% each.
Over 2.33 crore Ispat Industries shares changed hands on the BSE followed by RNRL (1.32 crore shares), Orchid Chemicals (1.17 crore shares), IFCI (1.13 crore shares) and RPL (1.02 crore shares).
Valuewise, Reliance Capital clocked a turnover of Rs324 crore followed by GSS America (Rs289 crore), Reliance Industries (Rs257 crore), Orchid Chemicals (Rs187 crore) and RPL (Rs162 crore).
| | | | | | | | European Indices at 16:35 IST on 31-03-2008 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 5677.70 | -15.20 | -0.27 | | CAC 40 Index | 4680.04 | -15.88 | -0.34 | | DAX Index | 6476.64 | -83.26 | -1.27 | | | | | | | | | | | Asian Indices at close on 31-03-2008 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 12525.54 | -294.93 | -2.30 | | Hang Seng Index | 22849.20 | -726.85 | -4.44 | | Kospi Index | 1703.99 | 2.16 | 0.13 | | Straits Times Index | 3344.53 | - | - | | Jakarta Composite Index | 2447.30 | -30.29 | -1.22 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
